Literature DB >> 18444893

Age-related decline in immunity: implications for vaccine responsiveness.

Rajesh Kumar1, Edith A Burns.   

Abstract

Aging is associated with declines in immune system function, or 'immunosenescence', leading to progressive deterioration in both innate and adaptive immunity. These changes contribute to the decreased response to vaccines seen in many older adults, and morbidity and mortality from infection. Infections (e.g., influenza, pneumonia and septicemia) appear among the top ten most-common causes of death in adults in the USA aged 55 years and older. As immunosenescence has gathered more attention in the scientific and healthcare communities, investigators have demonstrated more links between immunosenescent changes and morbidity and mortality related to infections and declining vaccine responses. This review summarizes the recent literature on age-dependent defects in adaptive and innate immunity, data linking these defects to poor vaccine response and morbidity and mortality, current recommendations for vaccinations and potential strategies to improve vaccine efficacy in older adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444893     DOI: 10.1586/14760584.7.4.467

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  54 in total

Review 1.  [Immunosenescence and vaccinations in the elderly].

Authors:  Hans Joachim Hutt; Petra Bennerscheidt; Britta Thiel; Manuela Arand
Journal:  Med Klin (Munich)       Date:  2010-12-07

2.  Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health Studies.

Authors:  Simone P Pinheiro; Susan E Hankinson; Shelley S Tworoger; Bernard A Rosner; John R McKolanis; Olivera J Finn; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

3.  Periodontal bone loss and risk of epithelial ovarian cancer.

Authors:  Ana Babic; Elizabeth M Poole; Kathryn L Terry; Daniel W Cramer; Ricardo P Teles; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2015-04-03       Impact factor: 2.506

Review 4.  Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.

Authors:  Matthew Frieman; Ralph Baric
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

5.  Melatonin and tumeric ameliorate aging-induced changes: implication of immunoglobulins, cytokines, DJ-1/NRF2 and apoptosis regulation.

Authors:  Ismail Ahmed Ismail; Hanan A El-Bakry; Safaa S Soliman
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-04-20

6.  Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.

Authors:  Mary S Hayney; Christopher L Coe; Daniel Muller; Chidi N Obasi; Uba Backonja; Tola Ewers; Bruce Barrett
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

7.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

9.  Towards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccine.

Authors:  René Segura-Velázquez; Gladis Fragoso; Edda Sciutto; Adelaida Sarukhan
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

10.  Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes.

Authors:  Daniel J Livorsi; Jessica R Macneil; Amanda C Cohn; Joseph Bareta; Shelly Zansky; Susan Petit; Ken Gershman; Lee H Harrison; Ruth Lynfield; Arthur Reingold; William Schaffner; Ann Thomas; Monica M Farley
Journal:  J Infect       Date:  2012-08-15       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.